Additionally, semaglutide has been shown in experimental models to increase GPx activities and decrease lipid peroxidation (MDA levels) through the PI3K/Akt/Nrf2 signaling pathway (44)
Though most weight loss patches are marketed as GLP-1 patches, they do not contain a GLP-1 agonist, such as semaglutide or tirzepatide
nutrigenomic studies argue that tailoring dose and formulation to such variants can optimize outcomes and reduce pill burden (94, 95)
By stratifying the analysis by comparator type we seek to provide a clearer understanding of the relative efficacy of GLP-1 RAs in modulating these critical pathways and to elucidate the mechanisms underlying their established cardiovascular benefits
A Holistic Viewpoint GLP-1 medications intersect with surgical care across three domains: surgical timing and technique, metabolic and glycemic control, and pharmacologic effects that influence perioperative risk
Common Side Effects vs Serious Concerns When discussing GLP-1 side effects, its important to distinguish between common, manageable side effects and rare, serious concerns